Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.

Employee Rating

2.0More
TypePublic
HQHayward, US
Founded1991
Size (employees)23 (est)
Websitearadigm.com
Aradigm was founded in 1991 and is headquartered in Hayward, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Aradigm

Igor Gonda

Igor Gonda

President & Chief Executive Officer
Nancy Pecota

Nancy Pecota

CFO
Juergen Froehlich

Juergen Froehlich

Chief Medical Officer
David Cipolla

David Cipolla

Vice President Preclinical R&D
Show more

Aradigm Office Locations

Aradigm has an office in Hayward
Hayward, US (HQ)
3929 Point Eden Way
Show all (1)
Report incorrect company information

Aradigm Financials and Metrics

Aradigm Revenue

Aradigm's revenue was reported to be $14.47 m in FY, 2017
USD

Revenue (Q2, 2018)

1.7m

EBIT (Q2, 2018)

(6.5m)

Market capitalization (14-Dec-2018)

7.3m

Closing stock price (14-Dec-2018)

0.5

Cash (30-Jun-2018)

2.1m
Aradigm's current market capitalization is $7.3 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

9.7m33.6m23.4m195.0k14.5m

Revenue growth, %

245%(30%)(99%)

General and administrative expense

4.8m5.3m5.8m7.6m

R&D expense

8.9m35.3m24.4m13.8m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

4.6m6.6m12.2m6.6m8.8m10.0m4.7m6.0k14.0k50.0k1.7m7.7m2.7m1.5m1.7m

General and administrative expense

1.5m1.7m1.9m1.4m1.5m1.3m1.3m1.6m1.4m1.5m1.7m1.9m1.7m3.1m

R&D expense

1.6m5.8m11.7m6.0m8.4m9.8m8.9m6.5m6.2m5.8m2.8m3.8m3.6m5.2m

Operating expense total

19.0m7.5m13.6m7.5m9.9m11.1m10.2m8.1m7.6m7.3m4.5m5.7m5.7m5.3m8.3m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

48.1m48.0m31.5m22.6m7.1m

Accounts Receivable

92.0k150.0k499.1m200.0k

Inventories

Current Assets

49.7m50.5m35.2m24.8m7.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

38.7m41.7m50.3m48.5m48.6m49.0m40.0m22.4m31.2m28.5m17.2m12.0m12.6m1.4m2.1m

Accounts Receivable

2.7m440.0k40.0k319.0k340.0k183.0k80.0k

Current Assets

53.3m45.9m52.6m49.8m50.8m50.9m41.6m26.5m35.7m32.0m19.7m13.0m13.6m2.3m2.8m

PP&E

461.0k493.0k539.0k582.0k416.0k353.0k325.0k310.0k282.0k278.0k225.0k227.0k256.0k223.0k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(21.6m)4.7m(17.2m)(32.9m)(10.7m)

Depreciation and Amortization

370.0k310.0k203.0k121.0k118.0k

Inventories

Accounts Payable

289.0k2.1m(917.0k)(1.1m)193.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(14.9m)7.8m(1.4m)(914.0k)(2.3m)(5.5m)(25.0m)(3.7m)(2.6m)(4.8m)(8.6m)

Depreciation and Amortization

74.0k149.0k90.0k28.0k55.0k34.0k67.0k

Accounts Payable

947.0k4.0m1.4m2.0m312.0k1.9m2.5m1.2m(1.0m)(179.0k)347.0k980.0k(69.0k)(508.0k)

Cash From Operating Activities

(6.3m)876.0k(21.7m)(5.4m)(11.6m)(5.8m)(9.0m)
Show all financial metrics

Aradigm Operating Metrics

FY, 2014FY, 2015FY, 2016

Patents Issued

82 82 80

Patents Pending

35 27 49
Show all operating metrics
Report incorrect company information

Aradigm Online and Social Media Presence

Embed Graph
Report incorrect company information

Aradigm News and Updates

Global Sustained Release Excipients Market 2018-2026 Featuring Key Companies - Coating Place, Depomed, Corium International, Capsugel, Aradigm, Orbis Biosciences & Alkermes

DUBLIN, Oct. 30, 2018 /PRNewswire/ -- The "Sustained Release Excipients Market Size, Share & Trends Analysis Report By Product (Polymers, Gelatin), By Route of Administration (Oral, Transdermal), By Technology (Targeted Delivery), And Segment Forecasts, 2018 - 2026" report has been added...

Bronchiectasis Treatment Market: Industry Drivers, Opportunities, Trends and Forecasts 2017 - 2025

The global bronchiectasis treatment market is expected to register a significant CAGR over a forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

Bronchiectasis Treatment Market Is Expected To Generate Huge Profits by 2025

Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

Aradigm Blogs

Dr. Theresa Matkovits

Dr. Theresa Matkovits kriscinimiguel… Tue, 08/14/2018 - 14:05 Member of the Audit Committee Member of the Nominating and Governance Committee Dr. Theresa Matkovits Chief Operating Officer ContraVir Pharmaceuticals

Aradigm Announces Second Quarter 2018 Financial Results

HAYWARD, Calif. --(BUSINESS WIRE)--Aug. 14, 2018-- Aradigm Corporation (NASDAQ: ARDM) (the “Company”) today announced financial results for the second quarter and six months ended June 30, 2018 . Second Quarter 2018 Financial Results The Company recorded $256,000 in revenue in the second quarter of

Aradigm Company Life and Culture

Report incorrect company information

Aradigm Frequently Asked Questions

  • When was Aradigm founded?

    Aradigm was founded in 1991.

  • Who are Aradigm key executives?

    Aradigm's key executives are Igor Gonda, Nancy Pecota and Juergen Froehlich.

  • How many employees does Aradigm have?

    Aradigm has 23 employees.

  • What is Aradigm revenue?

    Latest Aradigm annual revenue is $14.5 m.

  • What is Aradigm revenue per employee?

    Latest Aradigm revenue per employee is $628.9 k.

  • Who are Aradigm competitors?

    Competitors of Aradigm include 3SPharma, Biotage and Canopy Biosciences.

  • Where is Aradigm headquarters?

    Aradigm headquarters is located at 3929 Point Eden Way, Hayward.

  • Where are Aradigm offices?

    Aradigm has an office in Hayward.

  • How many offices does Aradigm have?

    Aradigm has 1 office.